TCM
Telos Capital Management Portfolio holdings
AUM
$982M
1-Year Est. Return
13.35%
1 Year Est. Return
+13.35%
AUM
$918M
AUM Growth
-$19.8M
(-2.1%)
Holding
205
Top Buys
| 1 | +$6.72M | |
| 2 | +$2.59M | |
| 3 | +$1.7M | |
| 4 |
PepsiCo
PEP
|
+$1.03M |
| 5 |
Exxon Mobil
XOM
|
+$850K |
Top Sells
| 1 | +$5.56M | |
| 2 | +$3.9M | |
| 3 | +$3M | |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$2.51M |
| 5 |
Visa
V
|
+$1.53M |
Sector Composition
| 1 | Technology | 17.74% |
| 2 | Financials | 13.6% |
| 3 | Industrials | 10.62% |
| 4 | Healthcare | 10.36% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Regeneron Pharmaceuticals
REGN
$61.3B
| – | – |
-301
|
|
||
202
Simulations Plus
SLP
$359M
| – | – |
-7,724
|
|
||
203
Vanguard Mid-Cap ETF
VO
$89.2B
| – | – |
-856
|
|
||
|
204
SPDR S&P Biotech ETF
XBI
$6.28B
| – | – |
-27,816
|
|
||
205
GE Vernova
GEV
$159B
| – | – |
-961
|
|